Unlike in the invasive ductal carcinoma of the breast with approximately 20% being HER2 amplified, previous studies have shown that HER2 is rarely overexpressed in the ILC especially in the classical type (cILC) which presents predominantly luminal A type [28,29,30,31,34,37,38]. The gene discussed is ERBB2; the disease is invasive ductal breast carcinoma.